Advisory Board & Committees
Technical Reports Review Subcommittee - August 28, 2006
Draft Reports, Public Comments & Meeting Presentations
- Overview of genetically modified models (Dr. John French, NIEHS)
-
GMM-07: Toxicology Studies of Allyl Bromide (CAS No. 106-95-6) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Studies of Allyl Bromide in Genetically Modified [B6.129-Trp53tm1Brd
(N5) Haploinsufficient] Mice (Gavage Studies)
(abstract) (full draft report) -
Public Comments: none received
-
Meeting Presentation
-
GMM-08: Toxicology and Carcinogenesis Study of
Benzene (CAS No. 71-43-2) in Genetically Modified Haploinsufficient p16Inka4a/p19Arf
Mice (Gavage Study)
(abstract) (full draft report)
- Public Comments: none received
-
Meeting Presentation
-
GMM-09:
Toxicology Studies of
Dicyclohexylcarbodiimide
(CAS No. 538-75-0) in F344/N Rats, B6C3F1
Mice, and Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Study of Dicyclohexylcarbodiimide in Genetically Modified [B6.129-Trp53tm1Brd
(N5) Haploinsufficient] Mice (Dermal Studies)
(abstract) (full draft report)
- Public Comments: none received
-
Meeting Presentation
-
GMM-12: Toxicology and Carcinogenesis Study of
Phenolphthalein
(CAS No. 77-09-8) in Genetically Modified Haploinsufficient p16Ink4a/p19Arf
Mice (Feed Study)
(abstract) (full draft report)
- Public Comments: none received
-
Meeting Presentation
-
GMM-13: Toxicology and Carcinogenesis Study of
Glycidol
(CAS No. 556-52-5) in Genetically Modified Haploinsufficient p16Ink4a/p19Arf
Mice (Gavage Study)
(abstract) (full draft report)
- Public Comments: will be added as received
-
Meeting Presentation
- Utility of genetically modified models for cancer hazard identification (Dr. John Bucher, NIEHS)
Web page last updated on May 01, 2007